Recent events
Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.
Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.
| Date | Company | Event | Filing |
|---|---|---|---|
| Bluejay Diagnostics, Inc. BJDX | Regulation FD disclosure Item 7.01 | Form 8-K | |
| BranchOut Food Inc. BOF | Results announced Item 2.02 | Form 8-K | |
| CAPRICOR THERAPEUTICS, INC. CAPR | Results announced Item 2.02 | Form 8-K | |
| CHEETAH NET SUPPLY CHAIN SERVICE INC. CTNT | Results announced Item 2.02 | Form 8-K | |
| CIRCLE8 GROUP INC CIRC | Material agreement signed Item 1.01 | Form 8-K | |
| CIRCLE8 GROUP INC CIRC | Delisting notice Item 3.01 | Form 8-K | |
| CIRCLE8 GROUP INC CIRC | Other event Item 8.01 | Form 8-K | |
| COLLEGIUM PHARMACEUTICAL, INC COLL | Other event Item 8.01 | Form 8-K | |
| CPI AEROSTRUCTURES INC CVU | Results announced Item 2.02 | Form 8-K | |
| CREATIVE REALITIES, INC. CREX | Results announced Item 2.02 | Form 8-K | |
| CYTOKINETICS INC CYTK | Other event Item 8.01 | Form 8-K | |
| Cabaletta Bio, Inc. CABA | Results announced Item 2.02 | Form 8-K | |
| Cadrenal Therapeutics, Inc. CVKD | Results announced Item 2.02 | Form 8-K | |
| CaliberCos Inc. CWD | Results announced Item 2.02 | Form 8-K | |
| CaliberCos Inc. CWD | Regulation FD disclosure Item 7.01 | Form 8-K | |
| Calidi Biotherapeutics, Inc. CLDI | Results announced Item 2.02 | Form 8-K | |
| Calidi Biotherapeutics, Inc. CLDI | Regulation FD disclosure Item 7.01 | Form 8-K | |
| Camp4 Therapeutics Corp CAMP | Results announced Item 2.02 | Form 8-K | |
| Candel Therapeutics, Inc. CADL | Results announced Item 2.02 | Form 8-K | |
| CapsoVision, Inc CV | Material agreement signed Item 1.01 | Form 8-K | |
| CapsoVision, Inc CV | Results announced Item 2.02 | Form 8-K | |
| Caribou Biosciences, Inc. CRBU | Results announced Item 2.02 | Form 8-K | |
| Celcuity Inc. CELC | Results announced Item 2.02 | Form 8-K | |
| Cellectar Biosciences, Inc. CLRB | Results announced Item 2.02 | Form 8-K | |
| Chicago Atlantic BDC, Inc. LIEN | Results announced Item 2.02 | Form 8-K | |
| Chicago Atlantic BDC, Inc. LIEN | Regulation FD disclosure Item 7.01 | Form 8-K | |
| Cibus, Inc. CBUS | Results announced Item 2.02 | Form 8-K | |
| Cineverse Corp. CNVS | Results announced Item 2.02 | Form 8-K | |
| Cingulate Inc. CING | Results announced Item 2.02 | Form 8-K | |
| Cloudflare, Inc. NET | Material agreement signed Item 1.01 | Form 8-K | |
| Cloudflare, Inc. NET | New debt or obligation Item 2.03 | Form 8-K | |
| Cloudflare, Inc. NET | Unregistered share sale Item 3.02 | Form 8-K | |
| Cloudflare, Inc. NET | Other event Item 8.01 | Form 8-K | |
| Co-Diagnostics, Inc. CODX | Results announced Item 2.02 | Form 8-K | |
| Co-Diagnostics, Inc. CODX | Regulation FD disclosure Item 7.01 | Form 8-K | |
| Comstock Holding Companies, Inc. CHCI | Results announced Item 2.02 | Form 8-K | |
| CorMedix Inc. CRMD | Results announced Item 2.02 | Form 8-K | |
| Cullinan Therapeutics, Inc. CGEM | Regulation FD disclosure Item 7.01 | Form 8-K | |
| Cullinan Therapeutics, Inc. CGEM | Other event Item 8.01 | Form 8-K | |
| Cyngn Inc. CYN | Results announced Item 2.02 | Form 8-K |
Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.